Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SCLN - upgrade and $7.25 tgt
BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy
8:17 am ET 04/09/2010- StreetInsider
BWS Financial upgrades Sciclone Pharmaceuticals (Nasdaq: SCLN) from Hold to Buy with a new $7.25 price target.
The firm said, ..."to aid the growth of ZADAXIN, has been steadily adding to its sales force in China. It is becoming apparent that the Company has been gaining good traction with their product in China."
not familiar w/ BWS here but SCLN could get interesting w/ first speedbump @ $4.25
SCLN - upgrade and $7.25 tgt
BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy
8:17 am ET 04/09/2010- StreetInsider
BWS Financial upgrades Sciclone Pharmaceuticals (Nasdaq: SCLN) from Hold to Buy with a new $7.25 price target.
The firm said, ..."to aid the growth of ZADAXIN, has been steadily adding to its sales force in China. It is becoming apparent that the Company has been gaining good traction with their product in China."
not familiar w/ BWS here but SCLN could get interesting w/ first speedbump @ $4.25
RXII nice pop into close
OSUR testing 52wk hi
That would be a terrific tool for a procedural tool like me! Plz let us know when that's together. TIA
SQNM - Wedbush Starts Sequenom (SQNM) at Underperform, $0.50 Downside Price Target
8:35 am ET 04/07/2010 - StreetInsider
Wedbush initiates coverage on Sequenom Inc. (Nasdaq: SQNM) with an Underperform rating and $0.50 price target.
Shares of SQNM closed at $6.48 yesterday.
New here, Great ibox kgoodrich! Super info and just what I need...more $*(# to learn, can't wait to get started.
cccpmd - could I trouble you for your current take on CYTX? It appears to have built a nice base and is perky today.
love the volume! already 70% of ydays w/ day only 1/2 over
PMTI gets FDA appvl for laser instrument
PMTI- FDA appvz for laser device/instrument
CYTX - Still relearning everything I can. How is well is CYTX setting up for a ppl? TIA
nice NVAX alert, picked some up, thx
PMTI spike
TEAR Chart Question...
notice this morning the volume spike and price run fm 2.60 - 3.10 and the right back down.
how would you read that action? could it be possible someone trying to accumulate shares before some event/announcement/etc. let it get away from them and they forced it back down hoping nobody would notice? thanks.
Chart Question... I'll use TEAR as the example.
notice this morning the volume spike and price run fm 2.60 - 3.10 and the right back down.
how would you read that action, Z/RTN/etc. could it be assumed someone trying to accumulate shares let it get away from them and they forced it back down hoping nobody would notice? thanks.
BRCX - How does their chart look w/ current 8x34 cross? tia
Same goes for all those blue hairs from florida, lol!
Thx Dew, nice list for further ref & DD
jas2mel, short interest question...
Pozen, Inc. ( POZN) Short Interest
POZN
Pozen, Inc.NASDAQ-GM
Settlement Date Short Interest Avg Daily Share Volume Days To Cover
3/15/2010 1,582,282 118,617 13.339420
2/26/2010 1,675,721 52,975 31.632298
2/12/2010 1,672,468 108,389 15.430237
1/29/2010 1,577,491 93,429 16.884383
1/15/2010 1,635,486 77,727 21.041414
What's the boards take on FSYS following CLNE's announced agreement w/ ATT today to supply cng fueling stations and designing Republic Industries new fueling infrastructure? Thx
FSYS ? Anyone like it on the heals of CLNE agreement w/ ATT today?
SLXP making a go @ the 38 it ran following 3/25 fda ok
SLXP making a go @ the 38 it ran following 3/25 fda ok
SLXP perking, 52wk hi in reach
SOMX completes public offering of 6.9M shares @ $8.25
Somaxon Pharmaceuticals (SOMX) Sees Net Proceeds of $52.8 Million From Common Stock Offering
9:36 am ET 03/31/2010- StreetInsider
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced the closing of its previously announced public offering of 6,900,000 shares of its common stock, including 900,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters, at a price to the public of $8.25 per share. The net proceeds from the sale of the shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $52.8 million
No, it the completion of the 3/26 announced offering...
Somaxon Pharmaceuticals (SOMX) Sees Net Proceeds of $52.8 Million From Common Stock Offering
9:36 am ET 03/31/2010- StreetInsider
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced the closing of its previously announced public offering of 6,900,000 shares of its common stock, including 900,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters, at a price to the public of $8.25 per share. The net proceeds from the sale of the shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $52.8 million
SOMX announces completion of 6.9M share public offering @ $8.25
Somaxon Pharmaceuticals (SOMX) Sees Net Proceeds of $52.8 Million From Common Stock Offering
9:36 am ET 03/31/2010- StreetInsider
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced the closing of its previously announced public offering of 6,900,000 shares of its common stock, including 900,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters, at a price to the public of $8.25 per share. The net proceeds from the sale of the shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $52.8 million
SOMX announces completion of 6.9M share offering @ $8.25
lolol, i thought you were making a sarcastic response to why slxp was going up after getting a fda warning letter on their ad/mktg materials...
it is reverse logic
SLXP gets warning letter for false and misleading ad/promotional materials and they go up???
Salix Pharma (SLXP) Warned by U.S. FDA About Metozolv ODT Ads and Promotional Material
10:14 am ET 03/30/2010- StreetInsider
Salix Pharmaceuticals, Ltd. (SLXP) was warned today, by the U.S. FDA, about an advertisement and promotional material involving a drug used to treat gastroesophageal reflux disease after other treatments fail.
Specifically, the agency sent a warning letter to the company on March 19 about the drug Metozolv ODT, which was approved last September to treat reflux disease as well as diabetic gastroparesis. The letter was posted to the FDA's Web site Tuesday.
The FDA said a journal advertisement, a sales aid and other promotional material were "false or misleading because they omit and minimize risk information, broaden the indication of Metozolv ODT and contain unsubstantiated comparative and other claims."
The agency also said Salix failed to submit some of the materials prior to use or publication to the FDA as regulations require.
Shares of Salix are trading higher early, however, up 2.52% to $36.57.
NVAX pop hod
NVAX popping
NVAX popping
wtg - nicely done!
DCTH has had a nice week and found very little chatter about it. Here's one worth reading...
http://issuu.com/trackingcr/docs/delcathreport/1?mode=a_p
glta
s
NPSP - thoughts? has had a nice week following presentation @ Barclay's Gl.Hlth.Conf. on Tues. Hasn't got much mention anywhere. Found this on SA... http://seekingalpha.com/article/195751-nps-pharmaceuticals-good-news-on-horizon
POZN - Trying to be patient here, want to grab some eod weekend weenie sellers. I think we'll get the opp, thoughts?
tia
glta
s
SNSS perked and vol spike since 11:38am, news? tia
thnx for the input but don't they still have funding to secure and start clinical trials...those tea leaves suggest to me it's waaay out ahead of itself. I have none short, yet. my brokers got none...so far
glta
s